BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Exicure Signs MOU to Acquire GPCR USA and Advance Collaborative Research in Drug Development

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR ...

December 30, 2024 | News

New Therapeutics Venture GEMMABio Secures $34M in Seed Funding to Accelerate Gene Therapy Initiatives

Significant international investment defies sector trend GEMMA Biotherapeutics ("GEMMABio") – a new therapeutics company founded by gene therapy pio...

December 24, 2024 | News

PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma

Based on promising early clinical results from PeproMene Bio's PMB-102 Phase 1 study, they will receive $6M USD upfront plus an addit...

December 20, 2024 | News

Ayala Corporation Secures €50 Million Social Loan from ING to Boost Philippine Healthcare Initiatives

Ayala Corporation signed a €50 million (₱3.1 Billion) social loan from leading European bank ING to support AC Health's portfolio growth. Key...

December 19, 2024 | News

South Korea invests in Generate Biomedicines through Samsung to drive global biopharma innovation.

Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics disc...

December 18, 2024 | News

Australia’s Cartherics Secures $300K G-Rex Grant to Advance Manufacturing of Allo CAR-iNK Cells for Ovarian Cancer Trials

- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...

December 18, 2024 | News

Novo Holdings Completes Catalent Acquisition; Novo Nordisk Secures Strategic Manufacturing Sites

Analysis of Novo Holdings A/S’s Acquisition of Catalent and Novo Nordisk’s Strategic Expansion The imminent completion of ...

December 16, 2024 | Analysis

Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production

The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity&nb...

December 06, 2024 | News

Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies

Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...

November 29, 2024 | News

IPO Renaissance: Biopharma's Strategic Momentum Sets the Stage for 2025

The IPO class of 2024 has redefined the biopharma and life sciences landscape, marking a return to growth after a prolonged period of market caution. These...

November 27, 2024 | Report

Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets

Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...

November 21, 2024 | News

Japan’s GHIT Fund Invests JPY 578 Million to Advance Diagnostics and Treatments for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 million (USD 4.0 million) in four projects ai...

November 07, 2024 | News

Vitrian Invests $50M in AmplifyBio’s Manufacturing Enablement Center, Driving Biomanufacturing Growth in Central Ohio

-Vitrian, the leading end-to-end provider of investment capital and capacity building services for biomanufacturing, announced that it closed a $50 million...

November 06, 2024 | News

Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence

Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...

October 30, 2024 | News

Stay Connected